Parallel Group Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus Treated With Oral Antidiabetic(s).
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Exenatide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Amylin Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb
- 10 Jun 2017 Biomarkers information updated
- 18 Sep 2014 Results of a pooled analysis of trials NCT00641056, NCT01003184, and NCT00935532 were presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 09 Aug 2012 Results published in Clinical Therapeutics.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History